Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) Antibody (FITC)

Este producto es parte de BCAR scaffold protein, Cas family member
Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) Antibody (FITC)
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) Antibody (FITC)
Category
Primary Antibodies
Provider
Abbexa
Reference
abx334864

Description

BCAR1 Antibody (FITC) is a Rabbit Polyclonal against BCAR1.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Breast Cancer Anti-Estrogen Resistance 1 (BCAR1)
Immunogen: Recombinant Human Breast cancer anti-estrogen resistance protein 1 protein (68-218AA).
Host
Rabbit
Reactivity
Human
Detection Method
Laser Line: 488
Excitation/Emission: 499/515
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
FITC
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P56945
Gene ID
9564
Alias
BCAR1, CAS, CAS1, CASS1, CRKAS, P130Cas, Cas family scaffolding protein, Cas family scaffold protein, BCAR1 scaffold protein, Cas family member
Background
Antibody anti-BCAR1
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

BCAR1, also known as the Breast Cancer Anti-Estrogen Resistance 1 protein, is an important protein involved in the development of resistance to anti-estrogen therapies, such as tamoxifen, used in the treatment of estrogen receptor-positive breast cancer. BCAR1 plays a crucial role in cell signaling pathways that regulate cell survival, proliferation, and resistance to apoptosis. It is often upregulated in breast cancer cells that become resistant to estrogen receptor-targeted therapies. The protein interacts with several other signaling molecules involved in the regulation of cell motility and survival, contributing to the metastatic potential of breast cancer cells. Understanding BCAR1’s role in therapy resistance has significant implications for developing alternative therapeutic strategies for patients with estrogen receptor-positive breast cancer who develop resistance to current treatments.

Productos relacionados

abx010317

Breast Cancer Anti-Estrogen Resistance Protein 1 (BCAR1) Antibody

Breast Cancer Anti-Estrogen Resistance Protein 1 (BCAR1) Antibody is a Rabbit Polyclonal antibody for the detection of B…

Ver producto
abx012424

Breast Cancer Anti-Estrogen Resistance Protein 1 Phospho-Tyr410 (BCAR1 pY410) Antibody

Rabbit polyclonal antibody against p130 Cas protein. Immunogen region is Internal. Specificity is as follows for the rea…

Ver producto
abx034763

Breast Cancer Anti-Estrogen Resistance Protein 1 (Bcar1) Antibody

Docking protein which plays a central coordinating role for tyrosine kinase-based signaling related to cell adhesion. Im…

Ver producto